We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.8%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$14.5B
AUM Growth
+$1.96B
Cap. Flow
+$582M
Cap. Flow %
4.02%
Top 10 Hldgs %
31.8%
Holding
146
New
31
Increased
52
Reduced
23
Closed
24

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$319M
2
IMMU
Immunomedics Inc
IMMU
+$296M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$216M
4
NYT icon
New York Times
NYT
+$130M
5
HLT icon
Hilton Worldwide
HLT
+$129M

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$456M
2
WUBA
58.com Inc
WUBA
+$268M
3
CRM icon
Salesforce
CRM
+$181M
4
QGEN icon
Qiagen
QGEN
+$123M
5
CZR
Caesars Entertainment Corporation
CZR
+$97.2M

Sector Composition

Rank Sector Weight
1 Healthcare 40.81%
2 Communication Services 17.58%
3 Technology 8.21%
4 Financials 7.39%
5 Industrials 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPTX
126
DELISTED
Repare Therapeutics
RPTX
– –
-150,000
Closed -$4.65M
TGTX icon
127
TG Therapeutics
TGTX
$7.62B
– –
-1,500,000
Closed -$29.2M
UTHR icon
128
United Therapeutics
UTHR
$23.1B
– –
-350,000
Closed -$42.4M
VCYT icon
129
Veracyte
VCYT
$3.8B
– –
-850,000
Closed -$22M
AMTI
130
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
– –
-200,000
Closed -$5.03M
TCDA
131
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-500,000
Closed -$13.7M
AKUS
132
DELISTED
Akouos Inc
AKUS
– –
-225,000
Closed -$5.06M
CNST
133
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-350,000
Closed -$10.5M
PRNB
134
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
– –
-300,000
Closed -$17.9M
WUBA
135
DELISTED
58.com Inc
WUBA
– –
-4,965,212
Closed -$268M
FSCT
136
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
– –
-1,305,000
Closed -$27.7M
PTLA
137
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-1,844,757
Closed -$33.2M
CZR
138
DELISTED
Caesars Entertainment Corporation
CZR
– –
-8,015,000
Closed -$97.2M
2 3 4 5
6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Farallon Capital Management held 146 positions worth $14.5B, up 16% from $12.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Farallon Capital Management deployed $582M of net new capital in Q3 2020, opening 31 new positions and adding to 52 existing holdings. Its largest new stake was Boston Scientific: 8,275,919 shares worth $316M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 43% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Salesforce, an estimated $181M trimmed.

  • Farallon Capital Management's largest Q3 2020 buy was Boston Scientific: 8,275,919 shares worth $316M.
  • Farallon Capital Management added most to Alphabet (Google) Class C in Q3 2020, an estimated $216M increase.
  • Farallon Capital Management's biggest Q3 2020 reduction was Salesforce, cutting an estimated $181M.
  • Farallon Capital Management fully exited People Inc in Q3 2020, selling an estimated $456M.
  • Farallon Capital Management's ten largest holdings make up 32% of its $14.5B portfolio in Q3 2020.
  • Farallon Capital Management opened 31 new positions and closed 24 in Q3 2020.
  • Farallon Capital Management's portfolio value rose 16% quarter-over-quarter to $14.5B.

Based on Farallon Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.